GLUE icon

Monte Rosa Therapeutics

52 hedge funds and large institutions have $560M invested in Monte Rosa Therapeutics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 7 reducing their positions, and 11 closing their positions.

Holders
52
Holders Change
-1
Holders Change %
-1.89%
% of All Funds
0.82%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
10
Increased
25
Reduced
7
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Ensign Peak Advisors
51
Ensign Peak Advisors
Utah
$3K
Daiwa Securities Group
52
Daiwa Securities Group
Japan
$2K
Jennison Associates
53
Jennison Associates
New York
-$10.8M -530,065 Closed
APM
54
Avidity Partners Management
Texas
-$6.13M -300,000 Closed
OCA
55
Octagon Capital Advisors
New York
-$3.06M -150,000 Closed
VOYA Investment Management
56
VOYA Investment Management
Georgia
-$1.95M -95,355 Closed
E
57
Ergoteles
New York
-$1.52M -74,510 Closed
Prudential Financial
58
Prudential Financial
New Jersey
-$1.51M -73,845 Closed
EC
59
EcoR1 Capital
California
-$768K -37,593 Closed
D.E. Shaw & Co
60
D.E. Shaw & Co
New York
-$492K -24,085 Closed
DekaBank Deutsche Girozentrale
61
DekaBank Deutsche Girozentrale
Germany
-$293K -15,000 Closed
SG Americas Securities
62
SG Americas Securities
New York
-$135K -6,621 Closed
MIFH
63
Migdal Insurance & Financial Holdings
Israel
-$3K -124 Closed